Soluble oligomers are sufficient for transmission of a yeast prion but do not confer phenotype

Journal of Cell Biology

Volumn 203, Issue 2, 2013, Pages 197-204

  Dulle, Jennifer E ^a   Bouttenot, Rachel E ^a   Underwood, Lisa A ^a   True, Heather L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ENDOPEPTIDASE CLP; OLIGOMER; PRION PROTEIN;

AGAR GEL ELECTROPHORESIS; ARTICLE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HYDROLYSIS; MUTATION; NONHUMAN; PHENOTYPE; PRION; PRIORITY JOURNAL; SUCROSE GRADIENT; VIRUS INFECTIVITY; VIRUS TRANSMISSION; WESTERN BLOTTING;

EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, FUNGAL; GENOTYPE; HEAT-SHOCK PROTEINS; MUTATION; PEPTIDE TERMINATION FACTORS; PHENOTYPE; PRIONS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SOLUBILITY; TIME FACTORS;

EID: 84887506426     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201307040     Document Type: Article

References (37)

1. Bagriantsev, S., and S.W. Liebman. 2004. Specificity of prion assembly in vivo. [PSI+] and [PIN+] form separate structures in yeast. J. Biol. Chem. 279:51042-51048. http://dx.doi.org/10.1074/jbc. M410611200
2. Bagriantsev, S.N., E.O. Gracheva, J.E. Richmond, and S.W. Liebman. 2008. Variant-specific [PSI+] infection is transmitted by Sup35 polymers within [PSI+] aggregates with heterogeneous protein composition. Mol. Biol. Cell. 19:2433-2443. http://dx.doi.org/10.1091/mbc. E08-01-0078
3. Caughey, B., and P.T. Lansbury. 2003. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26:267-298. http://dx.doi.org/10.1146/annurev.neuro.26.010302.081142
4. Chernoff, Y.O., S.L. Lindquist, B. Ono, S.G. Inge-Vechtomov, and S.W. Liebman. 1995. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science. 268:880-884. http://dx.doi.org/10.1126/science.7754373
5. Chiti, F., and C.M. Dobson. 2006. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75:333-366. http://dx.doi.org/10.1146/annurev.biochem.75.101304.123901
6. Conway, K.A., J.D. Harper, and P.T. Lansbury. 1998. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4:1318-1320. http://dx.doi.org/10.1038/3311
7. Derkatch, I.L., Y.O. Chernoff, V.V. Kushnirov, S.G. Inge-Vechtomov, and S.W. Liebman. 1996. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics. 144:1375-1386.
8. Glover, J.R., and S. Lindquist. 1998. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell. 94:73-82. http://dx.doi.org/10.1016/S0092-8674(00)81223-4
9. Glover, J.R., and R. Lum. 2009. Remodeling of protein aggregates by Hsp104. Protein Pept. Lett. 16:587-597. http://dx.doi.org/10.2174/092986609788490087
10. Haass, C., and D.J. Selkoe. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8:101-112. http://dx.doi.org/10.1038/nrm2101
11. Kirkitadze, M.D., G. Bitan, and D.B. Teplow. 2002. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69:567-577. http://dx.doi.org/10.1002/jnr.10328
12. Klyubin, I., D.M. Walsh, C.A. Lemere, W.K. Cullen, G.M. Shankar, V. Betts, E.T. Spooner, L. Jiang, R. Anwyl, D.J. Selkoe, and M.J. Rowan. 2005. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 11:556-561. http://dx.doi.org/10.1038/nm1234
13. Kryndushkin, D.S., I.M. Alexandrov, M.D. Ter-Avanesyan, and V.V. Kushnirov. 2003. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J. Biol. Chem. 278:49636-49643. http://dx.doi.org/10.1074/jbc. M307996200
14. Lasmézas, C.I., J.P. Deslys, O. Robain, A. Jaegly, V. Beringue, J.M. Peyrin, J.G. Fournier, J.J. Hauw, J. Rossier, and D. Dormont. 1997. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science. 275:402-405. http://dx.doi.org/10.1126/science.275.5298.402
15. Lesné, S., M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher, and K.H. Ashe. 2006. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 440:352-357. http://dx.doi.org/10.1038/nature04533
16. Liebman, S.W., and I.L. Derkatch. 1999. The yeast [PSI+] prion: making sense of nonsense. J. Biol. Chem. 274:1181-1184. http://dx.doi.org/10.1074/jbc.274.3.1181
17. Lum, R., J.M. Tkach, E. Vierling, and J.R. Glover. 2004. Evidence for an unfolding/threading mechanism for protein disaggregation by Saccharomyces cerevisiae Hsp104. J. Biol. Chem. 279:29139-29146. http://dx.doi.org/10.1074/jbc. M403777200
18. Ness, F., P. Ferreira, B.S. Cox, and M.F. Tuite. 2002. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol. Cell. Biol. 22:5593-5605. http://dx.doi.org/10.1128/MCB.22.15.5593-5605.2002
19. Ohhashi, Y., K. Ito, B.H. Toyama, J.S. Weissman, and M. Tanaka. 2010. Differences in prion strain conformations result from non-native interactions in a nucleus. Nat. Chem. Biol. 6:225-230. http://dx.doi.org/10.1038/nchembio.306
20. Patino, M.M., J.J. Liu, J.R. Glover, and S. Lindquist. 1996. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science. 273:622-626. http://dx.doi.org/10.1126/science.273.5275.622
21. Paushkin, S.V., V.V. Kushnirov, V.N. Smirnov, and M.D. Ter-Avanesyan. 1996. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15:3127-3134.
22. Sajnani, G., C.J. Silva, A. Ramos, M.A. Pastrana, B.C. Onisko, M.L. Erickson, E.M. Antaki, I. Dynin, E. Vázquez-Fernández, C.J. Sigurdson, et al. 2012. PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP. PLoS Pathog. 8:e1002547. http://dx.doi.org/10.1371/journal.ppat.1002547
23. Sánchez, I., C. Mahlke, and J. Yuan. 2003. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature. 421:373-379. http://dx.doi.org/10.1038/nature01301
24. Satpute-Krishnan, P., and T.R. Serio. 2005. Prion protein remodelling confers an immediate phenotypic switch. Nature. 437:262-265. http://dx.doi.org/10.1038/nature03981
25. Satpute-Krishnan, P., S.X. Langseth, and T.R. Serio. 2007. Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. PLoS Biol. 5:e24. http://dx.doi.org/10.1371/journal.pbio.0050024
26. Serio, T.R., A.G. Cashikar, A.S. Kowal, G.J. Sawicki, J.J. Moslehi, L. Serpell, M.F. Arnsdorf, and S.L. Lindquist. 2000. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science. 289:1317-1321. http://dx.doi.org/10.1126/science.289.5483.1317
27. Shorter, J., and S. Lindquist. 2004. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science. 304:1793-1797. http://dx.doi.org/10.1126/science.1098007
28. Shorter, J., and S. Lindquist. 2006. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol. Cell. 23:425-438. http://dx.doi.org/10.1016/j.molcel.2006.05.042
29. Silveira, J.R., G.J. Raymond, A.G. Hughson, R.E. Race, V.L. Sim, S.F. Hayes, and B. Caughey. 2005. The most infectious prion protein particles. Nature. 437:257-261. http://dx.doi.org/10.1038/nature03989
30. Taguchi, H., and S. Kawai-Noma. 2010. Amyloid oligomers: diffuse oligomerbased transmission of yeast prions. FEBS J. 277:1359-1368. http://dx.doi.org/10.1111/j.1742-4658.2010.07569.x
31. Tanaka, M., P. Chien, N. Naber, R. Cooke, and J.S. Weissman. 2004. Conformational variations in an infectious protein determine prion strain differences. Nature. 428:323-328. http://dx.doi.org/10.1038/nature02392
32. Taneja, V., M.L. Maddelein, N. Talarek, S.J. Saupe, and S.W. Liebman. 2007. A non-Q/N-rich prion domain of a foreign prion, [Het-s], can propagate as a prion in yeast. Mol. Cell. 27:67-77. http://dx.doi.org/10.1016/j.molcel.2007.05.027
33. Tessarz, P., A. Mogk, and B. Bukau. 2008. Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation. Mol. Microbiol. 68:87-97. http://dx.doi.org/10.1111/j.1365-2958.2008.06135.x
34. Tipton, K.A., K.J. Verges, and J.S. Weissman. 2008. In vivo monitoring of the prion replication cycle reveals a critical role for Sis1 in delivering substrates to Hsp104. Mol. Cell. 32:584-591. http://dx.doi.org/10.1016/j.molcel.2008.11.003
35. Tkach, J.M., and J.R. Glover. 2004. Amino acid substitutions in the C-terminal AAA+ module of Hsp104 prevent substrate recognition by disrupting oligomerization and cause high temperature inactivation. J. Biol. Chem. 279:35692-35701. http://dx.doi.org/10.1074/jbc. M400782200
36. Tzaban, S., G. Friedlander, O. Schonberger, L. Horonchik, Y. Yedidia, G. Shaked, R. Gabizon, and A. Taraboulos. 2002. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry. 41: 12868-12875. http://dx.doi.org/10.1021/bi025958g
37. Vishveshwara, N., M.E. Bradley, and S.W. Liebman. 2009. Sequestration of essential proteins causes prion associated toxicity in yeast. Mol. Microbiol. 73:1101-1114. http://dx.doi.org/10.1111/j.1365-2958.2009.06836.x